Skip to main content
SpringerLink
Log in

Retinal Inflammation: Uveitis/Uveoretinitis

  • Protocol
  • First Online:
Animal Models for Retinal Diseases

Part of the book series: Neuromethods ((NM,volume 46))

Abstract

Retinal inflammatory disease of a putative autoimmune origin, known as autoimmune uveitis, affects 150,000 persons per year in the developed world and is a potentially blinding disease. The eye can be the only affected organ or uveitis can be part of a systemic syndrome. Animal models of uveitis induced by immunization with retinal antigens or through genetic engineering are used to study basic mechanisms, genetic control and therapeutic approaches. Although thymic expression of retinal antigens eliminates most autoreactive lymphocytes and positively selects natural regulatory T cells, peripheral tolerance to retina is inefficient due to the relative sequestration of retinal antigens. Therefore, residual autoreactive lymphocytes persist and can be activated by accidental encounter with self or a cross-reactive antigen. When exposed to retinal or cross-reactive antigens in the context of innate danger signals they mature into Th1 or Th17 effector cells that find their way into the eye. Upon recognition of specific antigen within the eye, they orchestrate a destructive inflammation by recruiting inflammatory leukocytes from the circulation. Regulatory T cells are also induced as part of the disease process and ultimately control inflammation and permit healing to take place. Novel immunotherapeutic approaches built upon the growing knowledge of basic mechanisms to target critical checkpoints in disease pathogenesis and restore immune homeostasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111(3):491-500 discussion

    Article  PubMed  Google Scholar 

  2. Nussenblatt RB, Whitcup SM (2004) Uveitis: fundamentals and clinical practice, 3rd edn. Mosby (Elsevier), Philadelphia, PA

    Google Scholar 

  3. Pennesi G, Caspi RR (2002) Genetic control of susceptibility in clinical and experimental uveitis. Int Rev Immunol 21(2-3):67-88

    Article  CAS  PubMed  Google Scholar 

  4. Caspi RR (2006) Animal models of autoimmune and immune-mediated uveitis. Drug Discov Today Dis Models 3:3-10 (http://dxdoiorg/101016/jddmec200605006)

    Google Scholar 

  5. Arayssi T, Hamdan A (2004) New insights into the pathogenesis and therapy of Behcet’s disease. Curr Opin Pharmacol 4(2):183-188

    Article  CAS  PubMed  Google Scholar 

  6. Gery I, Nussenblatt RB, Chan CC, Caspi RR (2002) Autoimmune diseases of the eye. The molecular pathology of autoimmune diseases, 2nd edn. Taylor and Francis, New York, NY, pp 978-998

    Google Scholar 

  7. Damico FM, Kiss S, Young LH (2005) Vogt-Koyanagi-Harada disease. Semin Ophthalmol 20(3):183-190

    Article  PubMed  Google Scholar 

  8. Monnet D, Brezin AP (2006) Birdshot chorioretinopathy. Curr Opin Ophthalmol 17(6):545-550

    Article  PubMed  Google Scholar 

  9. Ding X, Patel M, Chan CC (2009) Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 28(1):1-18

    Article  CAS  PubMed  Google Scholar 

  10. Agarwal RK, Caspi RR (2004) Rodent models of experimental autoimmune uveitis. Methods Mol Med 102:395-419

    CAS  PubMed  Google Scholar 

  11. Lai JC, Fukushima A, Wawrousek EF et al (1998) Immunotolerance against a foreign antigen transgenically expressed in the lens. Invest Ophthalmol Vis Sci 39(11):2049-2057

    CAS  PubMed  Google Scholar 

  12. Gregerson DS, Torseth JW, McPherson SW, Roberts JP, Shinohara T, Zack DJ (1999) Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis. J Immunol 163(2):1073-1080

    CAS  PubMed  Google Scholar 

  13. Ham DI, Kim SJ, Chen J et al (2004) Central immunotolerance in transgenic mice expressing a foreign antigen under control of the rhodopsin promoter. Invest Ophthalmol Vis Sci 45(3):857-862

    Article  PubMed  Google Scholar 

  14. Lambe T, Leung JC, Ferry H et al (2007) Limited peripheral T cell anergy predisposes to retinal autoimmunity. J Immunol 178(7):4276-4283

    CAS  PubMed  Google Scholar 

  15. Terrada C, Fisson S, De Kozak Y et al (2006) Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen. J Immunol 176(12):7171-7179

    CAS  PubMed  Google Scholar 

  16. Caspi RR, Chan CC, Leake WC, Higuchi M, Wiggert B, Chader GJ (1990) Experimental autoimmune uveoretinitis in mice. Induction by a single eliciting event and dependence on quantitative parameters of immunization. J Autoimmun 3(3):237-246

    Article  CAS  PubMed  Google Scholar 

  17. Xu H, Koch P, Chen M, Lau A, Reid DM, Forrester JV (2008) A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp Eye Res 87(4):319-326

    Article  CAS  PubMed  Google Scholar 

  18. Copland DA, Wertheim MS, Armitage WJ, Nicholson LB, Raveney BJ, Dick AD (2008) The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation. Invest Ophthalmol Vis Sci 49(12):5458-5465

    Article  PubMed  Google Scholar 

  19. Taneja V, David CS (1999) HLA class II transgenic mice as models of human diseases. Immunol Rev 169:67-79

    Article  CAS  PubMed  Google Scholar 

  20. Pennesi G, Mattapallil MJ, Sun SH et al (2003) A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest 111(8):1171-1180

    CAS  PubMed  Google Scholar 

  21. de Smet MD, Bitar G, Roberge FG, Gery I, Nussenblatt RB (1993) Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat. J Autoimmun 6(5):587-599

    Article  PubMed  Google Scholar 

  22. Lai JC, Lobanoff MC, Fukushima A et al (1999) Uveitis induced by lymphocytes sensitized against a transgenically expressed lens protein. Invest Ophthalmol Vis Sci 40(11):2735-2739

    CAS  PubMed  Google Scholar 

  23. Tang J, Zhu W, Silver PB, Su SB, Chan CC, Caspi RR (2007) Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol 178(9):5578-5587

    CAS  PubMed  Google Scholar 

  24. Szpak Y, Vieville JC, Tabary T et al (2001) Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A 98(5):2572-2576

    Article  CAS  PubMed  Google Scholar 

  25. de Kozak Y, Camelo S, Pla M (2008) Pathological aspects of spontaneous uveitis and retinopathy in HLA-A29 transgenic mice and in animal models of retinal autoimmunity: relevance to human pathologies. Ophthalmic Res 40(3-4):175-180

    Article  PubMed  Google Scholar 

  26. Anderson MS, Venanzi ES, Klein L et al (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298(5597):1395-1401

    Article  CAS  PubMed  Google Scholar 

  27. DeVoss J, Hou Y, Johannes K et al (2006) Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med 203(12):2727-2735

    Article  CAS  PubMed  Google Scholar 

  28. Ichikawa T, Taguchi O, Takahashi T et al (1991) Spontaneous development of autoimmune uveoretinitis in nude mice following reconstitution with embryonic rat thymus. Clin Exp Immunol 86(1):112-117

    Article  CAS  PubMed  Google Scholar 

  29. Zhang M, Vacchio MS, Vistica BP et al (2003) T cell tolerance to a neo-self antigen expressed by thymic epithelial cells: the soluble form is more effective than the membrane-bound form. J Immunol 170(8):3954-3962

    CAS  PubMed  Google Scholar 

  30. McPherson SW, Heuss ND, Gregerson DS (2009) Lymphopenia-induced proliferation is a potent activator for CD4+ T cell-mediated autoimmune disease in the retina. J Immunol 182(2):969-979

    CAS  PubMed  Google Scholar 

  31. Avichezer D, Grajewski RS, Chan CC et al (2003) An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J Exp Med 198(11):1665-1676

    Article  CAS  PubMed  Google Scholar 

  32. Grajewski RS, Silver PB, Agarwal RK et al (2006) Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J Exp Med 203(4):851-856

    Article  CAS  PubMed  Google Scholar 

  33. Takase H, Yu CR, Mahdi RM et al (2005) Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals. Int Immunol 17(8):1131-1140

    Article  CAS  PubMed  Google Scholar 

  34. Caspi RR (2006) Ocular autoimmunity: the price of privilege? Immunol Rev 213:23-35

    Article  PubMed  Google Scholar 

  35. McPherson SW, Roberts JP, Gregerson DS (1999) Systemic expression of rat soluble retinal antigen induces resistance to experimental autoimmune uveoretinitis. J Immunol 163(8):4269-4276

    CAS  PubMed  Google Scholar 

  36. Xu H, Wawrousek EF, Redmond TM et al (2000) Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis. Eur J Immunol 30(1):272-278

    Article  CAS  PubMed  Google Scholar 

  37. Gregerson DS, Heuss ND, Lehmann U, McPherson SW (2008) Evidence for extrathymic generation of regulatory T cells specific for a retinal antigen. Ophthalmic Res 40(3-4):154-159

    Article  PubMed  Google Scholar 

  38. Amadi-Obi A, Yu CR, Liu X et al (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13(6):711-718

    Article  CAS  PubMed  Google Scholar 

  39. Chi W, Yang P, Li B et al (2007) IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 119(5):1218-1224

    Article  CAS  PubMed  Google Scholar 

  40. Chi W, Zhu X, Yang P et al (2008) Upregulated IL-23 and IL-17 in behcet patients with active uveitis. Invest Ophthalmol Vis Sci 49(7):3058-3064

    Article  PubMed  Google Scholar 

  41. Luger D, Silver PB, Tang J et al (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205(4):799-810

    Article  CAS  PubMed  Google Scholar 

  42. Chen L, Yang P, Zhou H et al (2008) Decreased frequency and diminished function of CD4+CD25high regulatory T cells are associated with active uveitis in patients with Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci 49(8):3475-3482

    Google Scholar 

  43. Ke Y, Jiang G, Sun D, Kaplan HJ, Shao H (2008) Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis. Invest Ophthalmol Vis Sci 49(9):3999-4007

    Article  PubMed  Google Scholar 

  44. Han G, Shao H, Peng Y et al (2007) Suppressor role of rat CD8+CD45RClow T cells in experimental autoimmune uveitis (EAU). J Neuroimmunol 183(1-2):81-88

    Article  CAS  PubMed  Google Scholar 

  45. Caspi RR, Grubbs BG, Chan CC, Chader GJ, Wiggert B (1992) Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes. J Immunol 148(8):2384-2389

    CAS  PubMed  Google Scholar 

  46. Caspi RR, Silver PB, Chan CC et al (1996) Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol 157(6):2668-2675

    CAS  PubMed  Google Scholar 

  47. Sun B, Sun SH, Chan CC, Wiggert B, Caspi RR (1999) Autoimmunity to a pathogenic retinal antigen begins as a balanced cytokine response that polarizes towards type 1 in a disease-susceptible and towards type 2 in a disease-resistant genotype. Int Immunol 11(8):1307-1312

    Article  CAS  PubMed  Google Scholar 

  48. Nussenblatt RB, Dinning WJ, Fujikawa LS, Chan CC, Palestine AG (1985) Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol 103(10):1559-1562

    CAS  PubMed  Google Scholar 

  49. Nussenblatt RB, Fortin E, Schiffman R et al (1999) Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc Natl Acad Sci U S A 96(13):7462-7466

    Article  CAS  PubMed  Google Scholar 

  50. Nussenblatt RB (2002) Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int Rev Immunol 21(2-3):273-289

    Article  PubMed  Google Scholar 

  51. Yeh S, Wroblewski K, Buggage R et al (2008) High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. J Autoimmun 31(2):91-97

    Article  CAS  PubMed  Google Scholar 

  52. Agarwal RK, Kang Y, Zambidis E, Scott DW, Chan CC, Caspi RR (2000) Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest 106(2):245-252

    Article  CAS  PubMed  Google Scholar 

  53. Silver PB, Agarwal RK, Su SB et al (2007) Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J Immunol 179(8):5146-5158

    CAS  PubMed  Google Scholar 

  54. Caspi RR (2008) Immunotherapy of autoimmunity and cancer: the penalty for success. Nat Rev Immunol 8(12):970-976

    Article  CAS  PubMed  Google Scholar 

  55. Smith JR, Verwaerde C, Rolling F et al (2005) Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. Hum Gene Ther 16(9):1037-1046

    Article  CAS  PubMed  Google Scholar 

  56. Bejjani RA, Andrieu C, Bloquel C, Berdugo M, BenEzra D, Behar-Cohen F (2007) Electrically assisted ocular gene therapy. Surv Ophthalmol 52(2):196-208

    Article  PubMed  Google Scholar 

  57. Karabekian Z, Lytton SD, Silver PB, Sergeev YV, Schneck JP, Caspi RR (2005) Antigen/MHC class II/Ig dimers for study of uveitogenic T cells: IRBP p161-180 presented by both IA and IE molecules. Invest Ophthalmol Vis Sci 46(10):3769-3776

    Article  PubMed  Google Scholar 

  58. Buckner JH, Holzer U, Novak EJ, Reijonen H, Kwok WW, Nepom GT (2002) Defining antigen-specific responses with human MHC class II tetramers. J Allergy Clin Immunol 110(2):199-208

    Article  CAS  PubMed  Google Scholar 

  59. Cortes LM, Mattapallil MJ, Silver PB et al (2008) Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice. Invest Ophthalmol Vis Sci 49(5):1946-1956

    Article  PubMed  Google Scholar 

  60. Silver PB, Rizzo LV, Chan CC, Donoso LA, Wiggert B, Caspi RR (1995) Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci 36(5):946-954

    CAS  PubMed  Google Scholar 

  61. Namba K, Ogasawara K, Kitaichi N et al (1998) Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice. Clin Exp Immunol 111(2):442-449

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Chi-Chao Chan for providing EAU scoring criteria as well as histology pictures of EAU and human uveitis. We also thank Dr. Yishay Falick for providing mouse fundus pictures.

Author information

Authors and Affiliations

  1. Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD, USA

    Reiko Horai & Rachel R. Caspi

Authors
  1. Reiko Horai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachel R. Caspi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rachel R. Caspi .

Editor information

Editors and Affiliations

  1. Alcon Research Ltd., S. Freeway 6201, Forth Worth, 76134, U.S.A.

    Iok-Hou Pang

  2. Health Science Center, University of North Texas, Camp Bowie Blvd. 500, Fort Worth, 76107, U.S.A.

    Abbot F. Clark

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Horai, R., Caspi, R.R. (2010). Retinal Inflammation: Uveitis/Uveoretinitis. In: Pang, IH., Clark, A. (eds) Animal Models for Retinal Diseases. Neuromethods, vol 46. Humana Press. https://doi.org/10.1007/978-1-60761-541-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-541-5_11

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-540-8

  • Online ISBN: 978-1-60761-541-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation